搜索
市场行情
自选
新闻
分析
交易工具
选股器
扫码下载
一键诊股 让投资更聪明
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
登录
免费注册
搜索
免费注册
市场行情
/
股票
/
医药与医学研究
/
生物技术与医疗研究
/
vyne
/
财务摘要
Vyne Therapeutics Inc
VYNE
添加自选
28.560
USD
0.000
0.00%
交易中 (美东)
110.85M
总市值
亏损
市盈率 TTM
Vyne Therapeutics Inc
28.560
0.000
0.00%
概览
新闻分析
财务
股票评分
技术分析
预测
持股情况
股息
公司资料
财务摘要
利润表
资产负债表
现金流量表
公司收入
财报
公司估值
风险评估
概览
新闻分析
财务
股票评分
技术分析
预测
持股情况
股息
公司资料
财务摘要
利润表
资产负债表
现金流量表
公司收入
财报
公司估值
风险评估
VYNE 财务数据
通过专为投资者打造的一站式数据看板,全面查看 Vyne Therapeutics Inc 的财务状况。平台将复杂的财务报表整理为可自定义的视图,助您更轻松地进行财务分析。您可以查看最新年度财务报告,也可以通过利润表、资产负债表和现金流量表,按季度分析公司表现。借助实时财务指标,持续追踪公司的经营状况和市场表现更加便捷。
关键财务比率
总市值
110.85M
股息TTM
0.00
市盈率 TTM
-56.98
每股收益TTM
-0.50
营业收入
570.00K
净利润
-39.83M
净资产收益率
-63.16%
总资产收益率
-52.78%
Vyne Therapeutics Inc 财报日历
最新发布
5月 15, 2026
每股收益 / 预测值
-0.08
/-0.18
营业收入 / 预测值
86.00K
/200.00K
财务报表摘要
单季报
单季报+年报
单季报
年报
YOY
隐藏空白行
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
财务指标
每股收益
-2503.95%
-3.50
-1976.91%
-4.19
60.01%
-0.11
40.42%
-0.17
39.06%
-0.13
-37.50%
-0.20
-42.72%
-0.28
85.77%
-0.29
92.81%
-0.22
91.50%
-0.15
93.59%
-0.20
--
-2.01
--
-3.07
--
-1.73
--
-3.08
--
-4.18
--
--
--
--
--
--
--
--
营业收入
40.58%
97.00K
-57.43%
86.00K
54.76%
130.00K
39.67%
169.00K
-65.15%
69.00K
106.12%
202.00K
10.53%
84.00K
6.14%
121.00K
46.67%
198.00K
-1.01%
98.00K
1166.67%
76.00K
-31.74%
114.00K
7.14%
135.00K
-44.38%
99.00K
-99.74%
6.00K
-95.91%
167.00K
-57.29%
126.00K
-22.61%
178.00K
-46.52%
2.29M
24.99%
4.09M
净利润
47.75%
-3.01M
58.37%
-3.58M
59.77%
-4.84M
40.12%
-7.28M
38.82%
-5.75M
-37.80%
-8.61M
-94.28%
-12.02M
-84.64%
-12.16M
6.48%
-9.41M
-11.15%
-6.25M
37.78%
-6.19M
30.39%
-6.58M
-18.66%
-10.06M
-220.39%
-5.62M
14.04%
-9.95M
55.56%
-9.46M
57.46%
-8.48M
122.73%
4.67M
50.09%
-11.57M
13.87%
-21.29M
利润率
64.12%
-2988.66%
2.12%
-4168.60%
73.32%
-3815.38%
56.27%
-4394.08%
-75.53%
-8328.99%
33.12%
-4258.91%
-76.69%
-14302.38%
-88.66%
-10047.11%
36.19%
-4744.95%
-12.34%
-6368.37%
93.74%
-8094.74%
--
-5325.44%
--
-7435.56%
--
-5668.69%
--
-129350.00%
--
-5559.24%
--
--
--
--
--
--
--
--
毛利率
0.00%
100.00%
0.00%
100.00%
0.00%
100.00%
0.00%
100.00%
0.00%
100.00%
0.00%
100.00%
0.00%
100.00%
0.00%
100.00%
0.00%
100.00%
0.00%
100.00%
0.00%
100.00%
--
100.00%
--
100.00%
--
100.00%
--
100.00%
--
100.00%
--
--
--
--
--
--
--
--
资产负债率
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.00%
--
--
--
0.00%
--
0.00%
--
0.00%
--
0.00%
--
0.00%
--
--
--
--
--
--
--
--
利润表
营业收入
40.58%
97.00K
-57.43%
86.00K
54.76%
130.00K
39.67%
169.00K
-65.15%
69.00K
106.12%
202.00K
10.53%
84.00K
6.14%
121.00K
46.67%
198.00K
-1.01%
98.00K
1166.67%
76.00K
-31.74%
114.00K
7.14%
135.00K
-44.38%
99.00K
-99.74%
6.00K
-95.91%
167.00K
-57.29%
126.00K
-22.61%
178.00K
-46.52%
2.29M
24.99%
4.09M
营业利润
58.87%
-3.10M
58.51%
-3.82M
59.13%
-5.22M
40.48%
-7.79M
27.45%
-7.54M
-24.62%
-9.20M
-86.91%
-12.77M
-109.99%
-13.09M
-0.76%
-10.40M
-25.62%
-7.38M
14.43%
-6.83M
33.20%
-6.23M
-24.51%
-10.32M
32.40%
-5.88M
33.71%
-7.98M
47.50%
-9.33M
13.15%
-8.29M
10.93%
-8.69M
45.23%
-12.04M
24.33%
-17.78M
净利润
47.75%
-3.01M
58.37%
-3.58M
59.77%
-4.84M
40.12%
-7.28M
38.82%
-5.75M
-37.80%
-8.61M
-94.28%
-12.02M
-84.64%
-12.16M
6.48%
-9.41M
-11.15%
-6.25M
37.78%
-6.19M
30.39%
-6.58M
-18.66%
-10.06M
-220.39%
-5.62M
14.04%
-9.95M
55.56%
-9.46M
57.46%
-8.48M
122.73%
4.67M
50.09%
-11.57M
13.87%
-21.29M
资产负债表
流动资产
-46.95%
23.53M
-53.04%
25.79M
-53.43%
30.01M
-51.20%
35.89M
-47.07%
44.34M
-39.14%
54.91M
-32.85%
64.44M
319.94%
73.53M
264.89%
83.78M
173.22%
90.22M
150.72%
95.96M
-60.24%
17.51M
-55.78%
22.96M
-45.56%
33.02M
-39.42%
38.27M
-42.14%
44.05M
-59.57%
51.92M
-57.62%
60.65M
-27.59%
63.19M
-22.45%
76.13M
流动负债总额
-73.58%
1.54M
-89.94%
1.24M
-83.84%
2.40M
-68.06%
4.04M
-50.35%
5.84M
77.36%
12.29M
96.59%
14.82M
96.33%
12.66M
84.41%
11.75M
-7.83%
6.93M
-19.34%
7.54M
-5.70%
6.45M
-6.74%
6.37M
-12.45%
7.52M
-49.24%
9.35M
-67.43%
6.84M
-88.14%
6.83M
-60.15%
8.59M
-15.41%
18.41M
-9.46%
21.00M
总资产
-47.22%
23.60M
-54.14%
25.87M
-54.92%
30.16M
-52.58%
36.13M
-48.39%
44.72M
-38.45%
56.42M
-31.51%
66.91M
295.48%
76.20M
247.16%
86.65M
159.98%
91.68M
139.67%
97.69M
-58.93%
19.27M
-54.78%
24.96M
-45.17%
35.26M
-39.21%
40.76M
-42.31%
46.91M
-58.81%
55.19M
-56.88%
64.32M
-28.48%
67.05M
-24.49%
81.31M
总负债
-73.58%
1.54M
-89.94%
1.24M
-83.84%
2.40M
-68.06%
4.04M
-50.45%
5.84M
47.98%
12.29M
65.58%
14.82M
63.12%
12.66M
53.23%
11.78M
-5.96%
8.31M
-4.23%
8.95M
13.50%
7.76M
12.47%
7.69M
2.84%
8.83M
-49.24%
9.35M
-69.51%
6.84M
-88.43%
6.83M
-84.74%
8.59M
-67.27%
18.41M
-61.44%
22.43M
总权益
-43.26%
22.06M
-44.17%
24.64M
-46.69%
27.77M
-49.50%
32.09M
-48.07%
38.88M
-47.06%
44.13M
-41.30%
52.09M
452.26%
63.54M
333.47%
74.87M
215.43%
83.37M
182.48%
88.73M
-71.29%
11.51M
-64.28%
17.27M
-52.57%
26.43M
-35.41%
31.41M
-31.95%
40.07M
-35.43%
48.36M
-40.01%
55.73M
29.72%
48.64M
18.92%
58.89M
现金流量表
经营净额
81.56%
-1.99M
64.39%
-4.08M
58.17%
-3.76M
16.62%
-7.10M
-27.38%
-10.80M
-43.59%
-11.46M
-75.18%
-9.00M
-65.18%
-8.51M
11.42%
-8.48M
-45.71%
-7.98M
-32.57%
-5.14M
16.76%
-5.15M
-16.40%
-9.57M
39.40%
-5.48M
61.32%
-3.88M
64.72%
-6.19M
49.41%
-8.22M
27.98%
-9.04M
60.52%
-10.02M
25.79%
-17.54M
投资净额
-93.58%
300.00K
-76.30%
4.70M
-33.58%
8.46M
191.25%
4.40M
-75.42%
4.67M
655.65%
19.83M
120.43%
12.74M
--
-4.82M
--
19.02M
-171.38%
-3.57M
-6568.88%
-62.35M
100.00%
0.00
--
0.00
-68.26%
5.00M
--
-935.00K
--
-1.02M
-100.00%
0.00
--
15.75M
-100.00%
0.00
--
0.00
融资净额
58.82%
-14.00K
82.76%
-15.00K
88.64%
-15.00K
-250.00%
-7.00K
-1033.33%
-34.00K
-2075.00%
-87.00K
-100.16%
-132.00K
95.74%
-2.00K
40.00%
-3.00K
98.16%
-4.00K
39641.83%
82.66M
-80.77%
-47.00K
91.80%
-5.00K
-114.16%
-217.00K
647.37%
208.00K
99.92%
-26.00K
52.71%
-61.00K
-97.92%
1.53M
-100.48%
-38.00K
-41025.61%
-33.56M
营业收入
业务
报告期:
暂无数据
地区
报告期:
暂无数据
常见问题
Vyne Therapeutics Inc的总收入是多少?
根据Vyne Therapeutics Inc的FY2025财报,总收入达到了570.00K(同比变化501.00K)。
Vyne Therapeutics Inc的流动资产是多少?
根据Vyne Therapeutics Inc的FY2025财报,流动资产为30.01M(同比变化-53.43)。
Vyne Therapeutics Inc的总资产是多少?
根据Vyne Therapeutics Inc的FY2025财报,Vyne Therapeutics Inc的总资产为30.16M(同比变化-54.92)。
Vyne Therapeutics Inc的总负债是多少?
根据Vyne Therapeutics Inc的FY2025财报,Vyne Therapeutics Inc的总负债为2.40M(同比变化-83.84)。
Vyne Therapeutics Inc的总权益是多少?
根据Vyne Therapeutics Inc的FY2025财报,Vyne Therapeutics Inc的总权益为27.77M(同比变化-46.69)。
Vyne Therapeutics Inc的净营业收入是多少?
根据Vyne Therapeutics Inc的FY2025财报,Vyne Therapeutics Inc的净营业收入为-29.75M(同比变化31.83)。
Vyne Therapeutics Inc的净投资是多少?
根据Vyne Therapeutics Inc的FY2025财报,Vyne Therapeutics Inc的净投资为37.37M(同比变化59.93)。
Vyne Therapeutics Inc的净融资是多少?
根据Vyne Therapeutics Inc的FY2025财报,Vyne Therapeutics Inc的净融资为-143.00K(同比变化-1.42)。
Vyne Therapeutics Inc的每股收益(EPS)是多少?
根据Vyne Therapeutics Inc的FY2025财报,每股收益(EPS)为-30.96(同比变化-3210.24)。
Vyne Therapeutics Inc的净利润是多少?
根据Vyne Therapeutics Inc的FY2025财报,净利润为-26.48M(同比变化33.52)。
Vyne Therapeutics Inc的净利润率是多少?
根据Vyne Therapeutics Inc的FY2025财报,净利润率为-4690.53(同比变化40.97)。
Vyne Therapeutics Inc的股东权益回报率(ROE)是多少?
根据Vyne Therapeutics Inc的FY2025财报,股东权益回报率(ROE)为-66.96(同比变化-18.45)。
Vyne Therapeutics Inc的资产回报率(ROA)是多少?
根据Vyne Therapeutics Inc的FY2025财报,资产回报率(ROA)为-55.09(同比变化-13.89)。
Vyne Therapeutics Inc的营业利润是多少?
根据Vyne Therapeutics Inc的FY2025财报,营业利润为-29.75M(同比变化31.83)。